Naprapathy Training for Postpartum DRAM Prevention

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-50
SponsorKarolinska Institutet

About this trial

A randomised controlled trial with the aim of analysing the effectiveness of a training program intended to prevent symptoms related to DRAM in the postpartum period.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Uni- and multiparous women 3-12 months postpartum

Ability to understand Swedish language

Ability participate in a three months follow-up program

Diastasis of the rectus abdominis muscles > 3 cm

Disqualifiers

Ongoing pregnancy

Age <18 years or >50 years

< 3 months or >12 months post partum

History of neurologic, musculoskeletal or psychiatric disorders

Trial design

Design model

Parallel

Treatments tested in this trial

  • Naprapathy training

    Behavioral

    Active training aimed at strengthening the abdominal muscles

  • Control group

    Other intervention

    No change of daily routines in regard to training

Treatment groups

70 Participants
are divided into 2 treatment groups
Group A: Naprapathy trainingActive comparator 1 intervention
Group B: Control groupPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Abdominal Trunk Function

Abdominal Trunk Function assessed with the Abdominal Trunk Function Protocol (ATFP). Six separate subscales.

Time frame
One year

Secondary outcomes

1

Disability

Disability rated with the Disability Rating index (DRI). Rates ranging from 0 to 1200, where high ratings indicate worse outcome.

Time frame
One year
2

Urinary Incontinence

Urinary incontinence rated with UDI-6 (urinary distress inventory). Rates ranging from 0 to 18, where high rates indicate worse outcome.

Time frame
One year
3

Health-related Quality of Life

Quality of Life rated with EQ-5D

Time frame
One year
4

Width of the diastasis

Width measured with ultrasound

Time frame
One year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Karolinska Institutet

Lead sponsor

Hela Kvinnans Klinik

Collaborator